Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hexa-, hepta-, and octapeptides having antiangiogenic activity

Hexa-, hepta-, and octapeptides having antiangiogenic activity

US Patent 7122625 · Granted Oct 17, 2006

Estimated economic value: $164,996,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of cyclin-dependent kinase 7 (CDK7)2025
Inhibitors of cyclin dependent kinase 7 (CDK7)2024
Heteroaromatic compounds useful for the treatment of proliferative diseases2021
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)2021
Inhibitors of cyclin-dependent kinase 7 (CDK7)2020
Inhibitors of cyclin-dependent kinase 7 (CDK7)2019
Salt and crystalline forms thereof of a drug2019
Inhibitors of cyclin-dependent kinase 7 (CDK7)2018
Inhibitors of cyclin-dependent kinase 7 (CDK7)2018
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)2018
Salt and crystalline forms thereof of a drug2018
Salt and crystalline forms thereof of a drug2017